Extensive research experience
Live human tumors studied
> 10 YEARS
Our journey began as Mitra Biotech over a decade ago and we renamed ourselves as Farcast Biosciences in 2019. We have pioneered human tumor histoculture science and consistently invested in learning and navigating the complex field of recreating near native human Tumor immune MicroEnvironment (TiME) ex vivo. We have validated an array of assays to ascertain drug induced response in human tumors. More than 25 Oncology companies have benefitted from working with us in progressing the development of their drug candidates.
Our ISO 7 (BSL2) NABL accredited lab in Bangalore, India is housed in a 28,000 sq feet facility. Our wide network of IRB approved cancer centers ensures access to fresh tumor samples from informed and consented patients